Telephone: 215-746-8598; FAX: 215-349-5915
Article first published online: 29 MAR 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 18, Issue 4, pages 434–443, April 2012
How to Cite
Goldberg, D., French, B., Abt, P., Feng, S. and Cameron, A. M. (2012), Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl, 18: 434–443. doi: 10.1002/lt.23394
This study was supported by the National Institutes of Health (grant 1-F32-DK-089694-01 from the National Institute of Diabetes and Digestive and Kidney Diseases to David Goldberg) and by the Health Resources and Services Administration (contract 234-2005-370011C). The contents of this article are the responsibility of the authors alone and do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
See Editorial on Page 381
- Issue published online: 29 MAR 2012
- Article first published online: 29 MAR 2012
- Accepted manuscript online: 23 JAN 2012 07:32AM EST
- Manuscript Accepted: 7 JAN 2012
- Manuscript Received: 3 NOV 2011
Additional Supporting Information may be found in the online version of this article.
|LT_23394_sm_SuppFig1.doc||96K||Supplementary Figure 1: Regional Variation in 90-day rates of waitlist removal for death or clinical deterioration|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.